spot_img
12.5 C
London
HomeInvestors HealthCentessa stock jumps 10% on Phase 1 narcolepsy study for ORX750

Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750



Centessa stock jumps 10% on Phase 1 narcolepsy study for ORX750



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here